Hyperuricaemia in type 2 diabetes mellitus (T2DM) has been less well investigated in sub-Saharan Africans. Our study of 438 patients found that alcohol intake, body mass index ≥25 kg/m2, hydrochlorothiazide use, statin use, diabetic retinopathy and glomerular filtration rate <60 mL/min/1.73m2 were independently positively associated with hyperuricaemia; whereas smoking reduced this risk. Hyperuricaemia is strongly associated with some modifiable factors, diabetic complications and certain drugs. Our results suggest that further studies should evaluate the potential cost–benefit of screening for hyperuricaemia in type 2 diabetes.
Levitt NS, Ohwovoriole E, Komlan T, Twahir A, Ramaiya K and Mbanya JC. Guide de prise en charge du diabete de type 2 pour l’afrique sub-saharienne. Region Afrique: Fédération Internationale du Diabète, 2005, p. 52.
4.
WangJChenRPLeiL. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr2013; 22: 590–598.
5.
XuYZhuJGaoL. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis. PLoS One2013; 8: e78206–e78206.
6.
OgberaAOAzenaborAO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr2010; 2: 24–24.
7.
GustafssonDUnwinR. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol2013; 14: 164–164.
8.
HaydenMRTyagiSC. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr Metab (Lond)2004; 1: 10–10.
9.
ZhangJXZhangYPWuQNChenB. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine2015; 48: 135–142.
10.
ChapmanPTYarwoodHHarrisonAA. Endothelial activation in monosodium urate monohydrate crystal-induced inflammation: in vitro and in vivo studies on the roles of tumor necrosis factor alpha and interleukin-1. Arthritis Rheum1997; 40: 955–965.
11.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care2009; 32(Suppl. 1): S62–67.
12.
CarrDBUtzschneiderKMHullRL. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes2004; 53: 2087–2094.
13.
ZoppiniGTargherGNegriC. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care2009; 32: 1716–1720.
14.
RocicBVucic-LovrencicMPojeNPojeMBertuzziF. Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residuein rat pancreatic beta-cells. Bioorg Med Chem Lett2005; 15: 1181–1184.
15.
ConenDWietlisbachVBovetP. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health2004; 4: 9–9.
16.
ChalèsGGuggenbuhlP. Hyperuricémies, une équation extra-articulaire à trois composantes: rénale, cardiovasculaire et métabolique. La Lettre du Rhumatologue2005; 314: 18–23.
17.
FukuiMTanakaMShiraishiE. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism2008; 57: 625–629.
18.
SheikhbahaeiSFotouhiAHafezi-NejadNNakhjavaniMEsteghamatiA. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes. Metab Syndr Relat Disord2014; 12: 102–109.
19.
TsengCH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int2005; 68: 796–801.
20.
HovindPRossingPJohnsonRJParvingHH. Serum uric acid as a new player in the development of diabetic nephropathy. J Ren Nutr2011; 21: 124–127.
21.
KangDHNakagawaTFengL. A role for uric acid in the progression of renal disease. J Am Soc Nephrol2002; 13: 2888–2897.
22.
MazzaliMKanellisJHanL. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol2002; 282: F991–997.
23.
NasharKFriedLF. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor?Adv Chronic Kidney Dis2012; 19: 386–391.
24.
SoltaniZRasheedKKapustaDRReisinE. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?Curr Hypertens Rep2013; 15: 175–181.
25.
WuDLiuHLiSH. [Association of elevated uric acid with metabolic disorders and analysis of the risk factors of hyperuricemia in type 2 diabetes mellitus]. Nan Fang Yi Ke Da Xue Xue Bao2011; 31: 544–547.
26.
XiaJWangZZhangF. Association between related purine metabolites and diabetic retinopathy in type 2 diabetic patients. Int J Endocrinol2014; 2014: 651050–651050.
27.
MilionisHJKakafikaAITsouliSG. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J2004; 148: 635–640.
28.
WunYTChanCSLuiCS. Hyperuricaemia in type 2 diabetes mellitus. Diabetes Nutr Metab1999; 12: 286–291.
29.
CulletonBFLarsonMGKannelWBLevyD. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med1999; 131: 7–13.
30.
GordonTKannelWB. Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study. Arch Intern Med1983; 143: 1366–1374.
31.
NakanishiNTataraKNakamuraKSuzukiK. Risk factors for the incidence of hyperuricaemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol1999; 28: 888–893.
32.
ShoeibSAbdel-AttiEDalaAGEl-NoamanyMKamalSMGabrHM. Is hyperuricaemia one of the cardiovascular risk factors clustering in type 2 diabetic patients?Life Science Journal2012; 9: 657–666.
